Surgical Treatment for Morbid Obesity by Sleeve Gastrectomy Versus Gastric Bypass
SLEEVE
1 other identifier
interventional
280
1 country
1
Brief Summary
The aim of this study is to assess that the sleeve gastrectomy can improve the risk benefit than the gastric bypass
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Jan 2008
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 25, 2008
CompletedFirst Posted
Study publicly available on registry
July 28, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedJune 15, 2021
June 1, 2021
7.3 years
July 25, 2008
June 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite criteria of morbid/mortality
during 18 months and 36 months
Secondary Outcomes (8)
Frequency of morbid events
during the follow up
Percentage of excess weight loss
during 18 and 36 months
Frequency of patients having a excess weight loss superior than 50%
during 36 months
Regression of morbidities
during 36 months
Rate serum ghrelin
at inclusion visit, 6, 12, 18 and 36 months
- +3 more secondary outcomes
Study Arms (2)
1
ACTIVE COMPARATORSleeve gastrectomy
2
ACTIVE COMPARATORGastric Bypass
Interventions
Laparoscopic sleeve gastrectomy is a restrictive procedure for the treatment for morbid obesity
Laparoscopic gastric bypass is a restrictive and difficult absorption procedure for the treatment of morbid obesity
Eligibility Criteria
You may qualify if:
- Patient aged from 18 to 60 years old
- Patient having given his consent to the use of data from the project
- Patient presenting one of the following criteria:
- A morbid obesity strict with BMI\> 40
- A super obesity BMI\> 50
- A super super obesity BMI\> 60
- Obese patient in failure following the installation of a gastric banding with BMI\> 35
- obese patient 35\>BMI\>40 with a comorbidity
- Preliminary agreement during the consultation of a psychiatrist / psychologist
You may not qualify if:
- Patient with complications or co morbidities associated involving life to less 6 months
- Patient presenting no anaesthetic indication
- Patient presenting no psychiatric indication for obesity surgery
- Patient not affiliated with a social security scheme
- Pregnant Patient likely to breastfeed in the first year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de chirurgie digestive / Centre Hospitalier Général de Saint-Denis Delafontaine
Saint-Denis, 93205, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Marc CATHELINE, MD, PhD
Assistance Publique - Hôpitaux de Paris / Hôpital De la Fontaine (St Denis)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2008
First Posted
July 28, 2008
Study Start
January 1, 2008
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
June 15, 2021
Record last verified: 2021-06